An intraocular lens can correct myopia within 0.5 D of the target in 79% of eyes and caused no vision-threatening complications. This was reported by Japanese investigators from the University of Kitasato in the July issue of Archives of Ophthalmology. “Our long-term results indicate that [implantable collamer lens (ICL)] implantation is safe and effective and provides predictable and stable refractive results in the correction of moderate to high myopia throughout a four-year observation,” the authors said. These findings suggest that ICL implantation may be a good alternative for the treatment of moderate to high myopia.

Cataract patients would now be able to see everything clearly from near and far with the use of a special type of lens called Crystalens. The lens, that has an ability to be flexible along the muscles of the eye, is the first and only accommodating intraocular lens that has received an FDA approval. Using the natural focusing ability of the eye, Crystalens is the only presbyopia correcting lens which provides a single focal point throughout a continuous range of vision to cataract patients.